New anticoagulant protein from medicinal leech
Biochemical and Biophysical Research Communications · 2024-02 · 696 · 149473
DOI: 10.1016/j.bbrc.2024.149473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024-02. Verfasst von Valentin A Manuvera und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435, Moscow, Malaya Pirogovskaya…. Hauptthemen laut MEDLINE: Anticoagulants, Hirudins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
The saliva of the medicinal leech contains various anticoagulants. Some of them, such as hirudin, are well known. However, it is reasonable to believe that not all anticoagulant proteins from medicinal leech saliva have been identified. We previously performed a comprehensive study of the transcriptome, genome, and proteome of leech salivary gland cells, which led to the discovery of several previously unknown hypothetical proteins that may have anticoagulant properties. Subsequently, we obtained a series of recombinant proteins and investigated their impact on coagulation in in vitro assays. We identified a previously undescribed protein that exhibited a high ability to suppress coagulation. The His-tagged recombinant protein was expressed in Escherichia coli and purified using metal chelate chromatography. To determine its activity, commonly used coagulation methods were used: activated partial thromboplastin time, prothrombin time, and thrombin inhibition clotting assay. Clotting and chromogenic assays for factor Xa inhibition were performed to evaluate anti-Xa activity. We used recombinant hirudin as a control anticoagulant protein in all experiments. The new protein showed significantly greater inhibition of coagulation than hirudin at the same molar concentrations in the activated partial thrombin time assay. However, hirudin demonstrated better results in the direct thrombin inhibition test, although the tested protein also exhibited the ability to inhibit thrombin. The chromogenic analysis of factor Xa inhibition revealed no activity, whereas the clotting test for factor Xa showed the opposite result. Thus, a new powerful anticoagulant protein has been discovered in the medicinal leech. This protein is homologous to antistatin, with 28 % identical amino acid residues. The recombinant protein was expressed in E. coli. This protein is capable of directly inhibiting thrombin, and based on indirect evidence, other proteases of the blood coagulation cascade have been identified.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435, Moscow, Malaya Pirogovskaya, 1a, Russia; Moscow Institute of Physics and Technology (National Res…
- Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, 119435, Moscow, Malaya Pirogovskaya, 1a, Russia.
Förderung
- Russian Science Foundation
Zitieren
APA
Manuvera, V. A., Kharlampieva, D. D., Bobrovsky, P. A., Grafskaia, E. N., Brovina, K. A., & Lazarev, V. N. (2024). New anticoagulant protein from medicinal leech. Biochemical and Biophysical Research Communications, 696, 149473. https://doi.org/10.1016/j.bbrc.2024.149473
Vancouver
Manuvera VA, Kharlampieva DD, Bobrovsky PA, Grafskaia EN, Brovina KA, Lazarev VN. New anticoagulant protein from medicinal leech. Biochemical and Biophysical Research Communications. 2024;696:149473. doi:10.1016/j.bbrc.2024.149473
BibTeX
@article{Manuvera2024,
author = {Manuvera, Valentin A and Kharlampieva, Daria D and Bobrovsky, Pavel A and Grafskaia, Ekaterina N and Brovina, Ksenia A and Lazarev, Vassili N},
title = {New anticoagulant protein from medicinal leech},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
volume = {696},
pages = {149473},
doi = {10.1016/j.bbrc.2024.149473}
}
EUVIMED